Skip to content
HowShorted

Stoke Therapeutics, Inc. short interest in 2026

In 2026, Stoke Therapeutics, Inc.'s disclosed short interest ran from 19.52% of shares outstanding on 15 Jan 2026 to 17.28% on 15 Sep 2026, a change of -2.24 percentage points. The year's high was 25.20% on 15 Jul 2026 and its low 17.28% on 15 Sep 2026, averaging 20.86% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.67 days on 31 Jul 2026. Full history: Stoke Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Stoke Therapeutics, Inc. in 2026

2026 in figures

Start of year
19.52% (15 Jan 2026)
End of year
17.28% (15 Sep 2026)
Change
-2.24 pp
High
25.20% (15 Jul 2026)
Low
17.28% (15 Sep 2026)
Average
20.86%
Highest days to cover
27.67 (31 Jul 2026)
SEC filings marked
6

Every report in 2026

Stoke Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202619.52%12.64results (8-K)
30 Jan 202619.58%18.31
13 Feb 202620.66%20.22
27 Feb 202621.71%18.91
13 Mar 202623.43%14.48
31 Mar 202622.44%12.6010-K filed
15 Apr 202621.95%20.80
30 Apr 202620.92%27.04
15 May 202620.74%24.7510-Q filed, results (8-K)
29 May 202618.03%19.13
15 Jun 202618.82%22.37
30 Jun 202622.33%10.01
15 Jul 202625.20%20.73
31 Jul 202624.50%27.67
14 Aug 202620.11%12.7010-Q filed, results (8-K)
31 Aug 202617.36%11.87
15 Sep 202617.28%17.31

See also: Stoke Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.